PAEDIATRIC COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS

摘要

H:/rbr/Intrwovn/NRPortbl/DCC/RBR/5852045_I.DOC-28/11/2013 The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2 (4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.